BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 3012355)

  • 1. A second post-transcriptional trans-activator gene required for HTLV-III replication.
    Sodroski J; Goh WC; Rosen C; Dayton A; Terwilliger E; Haseltine W
    Nature; 1986 May 22-28; 321(6068):412-7. PubMed ID: 3012355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.
    Rosen CA; Sodroski JG; Goh WC; Dayton AI; Lippke J; Haseltine WA
    Nature; 1986 Feb 13-19; 319(6054):555-9. PubMed ID: 3003584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trans-activator gene of HTLV-III is essential for virus replication.
    Fisher AG; Feinberg MB; Josephs SF; Harper ME; Marselle LM; Reyes G; Gonda MA; Aldovini A; Debouk C; Gallo RC
    Nature; 1986 Mar 27-Apr 2; 320(6060):367-71. PubMed ID: 3007995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.
    Inoue J; Yoshida M; Seiki M
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3653-7. PubMed ID: 3035544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell leukemia virus x gene.
    Wachsman W; Slamon D; Shimotohno K; Golde DW; Chen IS
    Cancer Res; 1985 Sep; 45(9 Suppl):4550s-4552s. PubMed ID: 2990685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and properties of the recombinant plasmid intended for the expression of a gene fragment of HTLV-III virus surface protein in Escherichia coli cells].
    Kovgan AA; Arakelov SA; Karamov EV; Zhdanov VM
    Dokl Akad Nauk SSSR; 1986; 288(2):487-90. PubMed ID: 3013556
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the gene expression of HTLV-I and its association with ATL.
    Yoshida M; Fujisawa J; Inoue J; Seiki M
    AIDS Res; 1986 Dec; 2 Suppl 1():S71-8. PubMed ID: 3030350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.
    Seiki M; Inoue J; Takeda T; Hikikoshi A; Sato M; Yoshida M
    Jpn J Cancer Res; 1985 Dec; 76(12):1127-31. PubMed ID: 3005203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic expressions of human T-lymphotropic virus (HTLV-I).
    Hatanaka M; Sabe H; Tanaka A; Mori K; Siomi H; Nam S; Adachi Y; Itamura S; Hirayoshi K
    AIDS Res; 1986 Dec; 2 Suppl 1():S79-85. PubMed ID: 3030351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
    Guyot DJ; Newbound GC; Lairmore MD
    Virology; 1997 Jul; 234(1):123-9. PubMed ID: 9234953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human T-cell leukemia/lymphotropic viruses: recent developments.
    Reitz MS; Gallo RC
    Prog Clin Biol Res; 1986; 209A():565-73. PubMed ID: 3018770
    [No Abstract]   [Full Text] [Related]  

  • 13. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic selection method for the transfer of HSV-1 glycoprotein B mutations from plasmid to the viral genome: preliminary characterization of transdominance and entry kinetics of mutant viruses.
    Desai P; Homa FL; Person S; Glorioso JC
    Virology; 1994 Oct; 204(1):312-22. PubMed ID: 8091662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.
    Wong-Staal F; Hahn BH; Shaw GM; Arya SK; Harper M; Gonda M; Gilden R; Ratner L; Starcich B; Okamoto T
    Princess Takamatsu Symp; 1984; 15():291-300. PubMed ID: 6100646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pX region of HTLV-I.
    Hatanaka M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():205-17. PubMed ID: 6100640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein.
    Diaz JJ; Dodon MD; Schaerer-Uthurralt N; Simonin D; Kindbeiter K; Gazzolo L; Madjar JJ
    Nature; 1996 Jan; 379(6562):273-7. PubMed ID: 8538795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the essential and non-essential transcription units for protein synthesis, DNA replication and infectious virus production of Porcine circovirus type 1.
    Cheung AK
    Arch Virol; 2004 May; 149(5):975-88. PubMed ID: 15098111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.
    Nicot C; Dundr M; Johnson JM; Fullen JR; Alonzo N; Fukumoto R; Princler GL; Derse D; Misteli T; Franchini G
    Nat Med; 2004 Feb; 10(2):197-201. PubMed ID: 14730358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.